About AFT Pharmaceuticals
What’s our company vision?
It’s pretty simple really, our vision is to develop innovative products that help people.
We do this by looking at healthcare needs, understanding how those needs are changing, and how we can provide treatment options that work.
We do this by looking at healthcare needs, understanding how those needs are changing, and how we can provide treatment options that work.
Our success as a company has been built on seeing opportunities in areas that others have missed.
Our guiding principle is to do things better than they've have been done before. Whether it’s developing products with multiple-benefits, creating drug delivery devices that produce less discomfort for patients, or getting lower-cost drugs to people with rare diseases, we're always focused on improving the status quo.
Novatears will be the major focus of the AFT Pharmaceuticals stand at WAVE in 2025, with the need for Evaporative Dry Eye solutions only increasing in prevalence. Combine that with our other innovative preservative-free eye solutions - HYLO® eye drops, VIZO-PF DORZOLATIM for use in Glaucoma treatment, OCUZO® antibiotic eye drops, OPTISOOTHE® masks and lid wipes, VITA-POS® ointment and CROMO-FRESH® allergy drops –we’ve got a lot to talk about.
Novatears will be the major focus of the AFT Pharmaceuticals stand at WAVE in 2025, with the need for Evaporative Dry Eye solutions only increasing in prevalence. Combine that with our other innovative preservative-free eye solutions - HYLO® eye drops, VIZO-PF DORZOLATIM for use in Glaucoma treatment, OCUZO® antibiotic eye drops, OPTISOOTHE® masks and lid wipes, VITA-POS® ointment and CROMO-FRESH® allergy drops –we’ve got a lot to talk about.